Related Experiment Video
Updated: Jun 12, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Pediatric obstructive sleep apnea syndrome
Eliot S Katz1, Carolyn M D'Ambrosio
1Division of Respiratory Diseases, Department of Medicine, Children's Hospital, Mailstop 208, 300 Longwood Avenue, Boston, MA 02115, USA. eliot.katz@childrens.harvard.edu
Insights
Obstructive sleep apnea syndrome (OSAS) in children causes serious health issues like metabolic and cardiovascular problems. Treatment for pediatric OSAS depends on its cause, how severe it is, and the patient
Area of Science:
- Pediatric Sleep Medicine
- Respiratory Medicine
- Childhood Morbidity
Background:
- Obstructive sleep apnea syndrome (OSAS) is a prevalent condition in children, significantly contributing to metabolic, cardiovascular, and neurocognitive health issues.
- Increased upper airway resistance during sleep in affected children stems from factors like soft tissue hypertrophy, craniofacial abnormalities, neuromuscular deficits, or obesity.
- OSAS in children triggers physiological disruptions including oxidative stress, inflammation, autonomic nervous system imbalance, and impaired sleep regulation.
Purpose of the Study:
- To elucidate the multifaceted health consequences of pediatric obstructive sleep apnea syndrome.
- To identify the underlying causes of increased upper airway resistance in children diagnosed with OSAS.
- To underscore the variability in OSAS impact based on genetic and environmental influences.
Main Methods:
- Review of existing literature on pediatric obstructive sleep apnea syndrome.
- Analysis of etiological factors contributing to upper airway resistance in children.
- Examination of genetic and environmental modulators of OSAS severity and impact.
Main Results:
- Children with OSAS experience a spectrum of adverse health outcomes.
- Upper airway resistance is multifactorial, involving anatomical and physiological components.
- Individual susceptibility to OSAS consequences varies significantly.
Conclusions:
- Therapeutic strategies for pediatric OSAS must be individualized.
- Treatment decisions should consider the specific etiology, disease severity, and clinical course.
- Understanding the variability in OSAS impact is crucial for effective management.
Abstract:
Obstructive sleep apnea syndrome (OSAS) is a common and serious cause of metabolic, cardiovascular, and neurocognitive morbidity in children. Children with OSAS have increased upper airway resistance during sleep due to a combination of soft tissue hypertrophy, craniofacial dysmorphology, neuromuscular weakness, or obesity. Consequently, children with OSAS encounter a combination of oxidative stress, inflammation, autonomic activation, and disruption of sleep homeostasis. The threshold amount of OSAS associated with adverse consequences varies widely among children, depending on genetic and environmental factors. The choice of therapy is predicated on the etiology, severity, and natural history of the increased upper airway resistance.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Other Pulmonary Disorders
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Suctioning the Oropharyngeal Airway
After assembling the equipment, the nurse should practice hand hygiene and don appropriate PPE according to infection control guidelines to avoid the...
